216 related articles for article (PubMed ID: 22553050)
1. The relevance of polymeric synthetic membranes in topical formulation assessment and drug diffusion study.
Ng SF; Rouse JJ; Sanderson FD; Eccleston GM
Arch Pharm Res; 2012 Mar; 35(4):579-93. PubMed ID: 22553050
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
3. Liposomes and skin: from drug delivery to model membranes.
El Maghraby GM; Barry BW; Williams AC
Eur J Pharm Sci; 2008 Aug; 34(4-5):203-22. PubMed ID: 18572392
[TBL] [Abstract][Full Text] [Related]
4. Epidermal lipids and topical drug delivery.
Hadgraft J; Walters KA; Guy RH
Semin Dermatol; 1992 Jun; 11(2):139-44. PubMed ID: 1498017
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
[TBL] [Abstract][Full Text] [Related]
6. [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].
Csizmazia E; Berkó S; Maroda M; Szabóné RP; Csányi E
Acta Pharm Hung; 2012; 82(1):15-22. PubMed ID: 22570983
[TBL] [Abstract][Full Text] [Related]
7. Membrane properties for permeability testing: Skin versus synthetic membranes.
Haq A; Dorrani M; Goodyear B; Joshi V; Michniak-Kohn B
Int J Pharm; 2018 Mar; 539(1-2):58-64. PubMed ID: 29366943
[TBL] [Abstract][Full Text] [Related]
8. Modeling the human skin barrier--towards a better understanding of dermal absorption.
Jepps OG; Dancik Y; Anissimov YG; Roberts MS
Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
[TBL] [Abstract][Full Text] [Related]
9. Bacterial cellulose membranes applied in topical and transdermal delivery of lidocaine hydrochloride and ibuprofen: in vitro diffusion studies.
Trovatti E; Freire CS; Pinto PC; Almeida IF; Costa P; Silvestre AJ; Neto CP; Rosado C
Int J Pharm; 2012 Oct; 435(1):83-7. PubMed ID: 22266531
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous absorption.
Brisson P
Can Med Assoc J; 1974 May; 110(10):1182-5. PubMed ID: 4597976
[TBL] [Abstract][Full Text] [Related]
11. Fish skin as a model membrane: structure and characteristics.
Konrádsdóttir F; Loftsson T; Sigfússon SD
J Pharm Pharmacol; 2009 Jan; 61(1):121-4. PubMed ID: 19126306
[TBL] [Abstract][Full Text] [Related]
12. Lateral diffusion of ibuprofen in human skin during permeation studies.
Schicksnus G; Müller-Goymann CC
Skin Pharmacol Physiol; 2004; 17(2):84-90. PubMed ID: 14976385
[TBL] [Abstract][Full Text] [Related]
13. In vitro human topical bioactive drug transdermal absorption: estradiol.
Xing MM; Hui X; Zhong W; Pan N; Yaghmaie F; Maibach HI
Cutan Ocul Toxicol; 2009; 28(4):171-5. PubMed ID: 19888886
[TBL] [Abstract][Full Text] [Related]
14. Breaching the skin barrier--insights from molecular simulation of model membranes.
Notman R; Anwar J
Adv Drug Deliv Rev; 2013 Feb; 65(2):237-50. PubMed ID: 22414344
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic applications of iontophoresis.
Sieg A; Wascotte V
J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
[TBL] [Abstract][Full Text] [Related]
16. Modeling of percutaneous drug transport in vitro using skin-imitating Carbosil membrane.
Feldstein MM; Raigorodskii IM; Iordanskii AL; Hadgraft J
J Control Release; 1998 Mar; 52(1-2):25-40. PubMed ID: 9685933
[TBL] [Abstract][Full Text] [Related]
17. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
18. A new FTIR-ATR cell for drug diffusion studies.
Hartmann M; Hanh BD; Podhaisky H; Wensch J; Bodzenta J; Wartewig S; Neubert RH
Analyst; 2004 Oct; 129(10):902-5. PubMed ID: 15457320
[TBL] [Abstract][Full Text] [Related]
19. Topical delivery of caffeine from some commercial formulations.
Dias M; Farinha A; Faustino E; Hadgraft J; Pais J; Toscano C
Int J Pharm; 1999 May; 182(1):41-7. PubMed ID: 10332073
[TBL] [Abstract][Full Text] [Related]
20. Vesicles as tools for the modulation of skin permeability.
Dubey V; Mishra D; Nahar M; Jain NK
Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
